Genital Diseases, Female  >>  glufosfamide (D 19575)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
glufosfamide (D 19575) / Eleison Pharma
NCT00442598: Safety and Efficacy Study of Glufosfamide in Ovarian Cancer

Terminated
2
17
US
Glufosfamide
Eleison Pharmaceuticals LLC.
Ovarian Cancer
04/08
04/08

Download Options